Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
Sarepta Therapeutics

Sarepta Therapeutics (SRPT) Earnings Prediction

Updated November 15, 2026 · AltIndex alt-data view going into the print

AltIndex AI Score on Sarepta Therapeutics is 46 — signals are mixed heading into the print. Underlying trend: 3 of 7 tracked signals trending up over the last 3 months.

Next report
Tuesday, February 23, 2027
EPS Estimate
$-1.03
AltIndex AI Score
46
AI Prediction
Mixed signals

SRPT stock price — last 3 months

Sarepta Therapeutics (SRPT) is trading at $16.07, down 11.6% over the last 3 months (from $18.18 three months ago).

What the alt-data signals say about Sarepta Therapeutics right now

Trends across the last 3 months — the run-up to Sarepta Therapeutics’s next earnings print.

Signal Current 3-month change
Job postings 59 ↑ +31.1%
LinkedIn headcount 1,175 → +0.3%
Sentiment 68% Bullish → flat
Web traffic 26,398 ↑ +17.2%
Employee business outlook 39% Negative → flat
Instagram followers 7,225 ↑ +6.4%
X followers 6,602 → +0.2%

Full daily-resolution trend charts on every signal are on the SRPT ticker page.

Get alerted when SRPT signals inflect

AltIndex stock alerts fire when alt-data on SRPT breaks out — web traffic spike, hiring surge, sentiment shift — often days before the earnings number confirms it.

Sign up to AltIndex →

Sarepta Therapeutics earnings: frequently asked questions

When does Sarepta Therapeutics report earnings next?
Sarepta Therapeutics (SRPT) is scheduled to report next earnings on Tuesday, February 23, 2027. The exact pre-market or post-market time is set by the company a few days ahead; see the official investor-relations page for confirmation.
What does the AltIndex AI Score say about Sarepta Therapeutics going into earnings?
Current AI Score on Sarepta Therapeutics: 46 — Mixed signals. The AI Score combines 10,000+ alternative-data and financial signals into one 0–100 number; higher = signals lean bullish, lower = signals lean bearish. Full per-signal breakdown is on the SRPT ticker page.
What is the EPS estimate for Sarepta Therapeutics?
Analyst consensus EPS estimate for Sarepta Therapeutics’s next quarter: $-1.03. We refresh this from analyst-estimate data daily.
How accurate are AltIndex’s earnings predictions for Sarepta Therapeutics?
AltIndex doesn’t predict the exact EPS number — the alt-data signals don’t see the financials. What the signals can do is tell you whether the underlying business momentum (web traffic, hiring, social audience, sentiment) supports the analyst consensus or contradicts it. AltIndex publishes the full pick history at altindex.com/results — including the misses — so you can verify how the signal-driven calls have performed.
Where can I see the full signal breakdown on Sarepta Therapeutics?
Visit https://altindex.com/ticker/srpt for the complete per-signal view: AI Score history, web traffic trend chart, 8-platform social audience tracking, hiring activity, news mention volume, sentiment scoring, insider trades and Congressional disclosures.
How can I get alerted before Sarepta Therapeutics reports earnings?
AltIndex stock alerts fire when alt-data signals on a stock break out of their historical range — often days or weeks before the earnings number confirms it. Add SRPT to your watchlist and you’ll get notified when its signals shift. See altindex.com/stock-alerts for the full alert categories.

See every alt-data signal on SRPT

Sign up to see the full daily-resolution trend charts on every signal AltIndex tracks for Sarepta Therapeutics — web traffic, hiring, 8-platform social audience, sentiment, insider trades and the full AI Score breakdown.

Sign up to AltIndex → Log in